The Influence of Chitosan on the Oral Bioavailability of Acyclovir—a Comparative Bioavailability Study in Humans
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-904X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Influence of Chitosan on the Oral Bioavailability of Acyclovir—a Comparative Bioavailability Study in Humans ; volume:32 ; number:7 ; day:22 ; month:1 ; year:2015 ; pages:2241-2249 ; date:7.2015
Pharmaceutical research ; 32, Heft 7 (22.1.2015), 2241-2249, 7.2015
- Urheber
-
Kubbinga, Marlies
- Beteiligte Personen und Organisationen
-
Nguyen, Mai Anh
Staubach, Petra
Teerenstra, Steven
Langguth, Peter
SpringerLink (Online service)
- DOI
-
10.1007/s11095-014-1613-y
- URN
-
urn:nbn:de:1111-2016030934037
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kubbinga, Marlies
- Nguyen, Mai Anh
- Staubach, Petra
- Teerenstra, Steven
- Langguth, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nanocarriers for oral bioavailability enhancement
Nanomedicine for increasing the oral bioavailability of cancer treatments
Nanosuspension for enhancement of oral bioavailability of felodipine
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Bioavailability and pharmacokinetics of oral meloxicam in llamas
Experimental determination of the oral bioavailability and bioaccessibility of lead particles
Influence of dietary fat on the oral bioavailability of the flavonol quercetin
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
Oral Bioavailability and Metabolism of Hydroxytyrosol from Food Supplements
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Nanocrystals & loaded porous silica for increased oral bioavailability
Nanocarriers for oral bioavailability enhancement
Nanomedicine for increasing the oral bioavailability of cancer treatments
Nanosuspension for enhancement of oral bioavailability of felodipine
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Bioavailability and pharmacokinetics of oral meloxicam in llamas
Experimental determination of the oral bioavailability and bioaccessibility of lead particles
Influence of dietary fat on the oral bioavailability of the flavonol quercetin
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
Oral Bioavailability and Metabolism of Hydroxytyrosol from Food Supplements
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Nanocrystals & loaded porous silica for increased oral bioavailability
Nanocarriers for oral bioavailability enhancement
Nanomedicine for increasing the oral bioavailability of cancer treatments
Nanosuspension for enhancement of oral bioavailability of felodipine
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability
Bioavailability and pharmacokinetics of oral meloxicam in llamas
Experimental determination of the oral bioavailability and bioaccessibility of lead particles
Influence of dietary fat on the oral bioavailability of the flavonol quercetin
Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone
Oral Bioavailability and Metabolism of Hydroxytyrosol from Food Supplements
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs